Mortalidad, Secuelas Clínicas y Calidad de Vida Luego del Alta de Unidades de Cuidados Intensivos en Pacientes con COVID-19: Estudio Multicéntrico Descriptivo en Argentina.

COVID prolongado COVID-19 calidad de vida intensive care unit long COVID mortalidad mortality quality of life unidad de cuidados intensivos

Journal

Value in health regional issues
ISSN: 2212-1102
Titre abrégé: Value Health Reg Issues
Pays: United States
ID NLM: 101592642

Informations de publication

Date de publication:
09 May 2024
Historique:
received: 27 06 2023
revised: 11 01 2024
accepted: 04 04 2024
medline: 11 5 2024
pubmed: 11 5 2024
entrez: 10 5 2024
Statut: aheadofprint

Résumé

Patients with COVID-19 who require hospitalization in an intensive care unit, in addition to being at risk of presenting premature death, have higher rates of complications. This study aimed to describe mortality, rehospitalizations, quality of life, and symptoms related to postintensive care syndrome (PICS) and prolonged COVID-19 in patients with COVID-19 discharged from the intensive care unit in hospitals in Argentina. A cross-sectional study was conducted in 4 centers in the Autonomous City and province of Buenos Aires as of December 2022. The variables of interest were mortality after discharge, rehospitalization, health-related quality of life, post-COVID-19-related symptoms, cognitive status, and PICS. Data collection was by telephone interview between 6 and 18 months after discharge. A total of 124 patients/families were contacted. Mortality was 7.3% (95% CI: 3.87-13.22) at 14.46 months of follow-up after discharge. Patients reported a reduction of the EQ-5D-3L visual analog scale of 13.8 points, reaching a mean of 78.05 (95% CI: 73.7-82.4) at the time of the interview. Notably, 54.4% of patients (95% CI: 41.5-66.6) reported cognitive impairment and 66.7% (95% CI: 53.7-77.5) developed PICS, whereas 37.5% (95% CI: 26-50.9) had no symptoms of prolonged COVID-19. The results showed a significant impact on the outcomes studied, consistent with international evidence.

Identifiants

pubmed: 38728912
pii: S2212-1099(24)00022-0
doi: 10.1016/j.vhri.2024.100989
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100989

Informations de copyright

Copyright © 2024 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Author Disclosures Author disclosure forms can be accessed below in the Supplemental Material section.

Auteurs

Fernando Argento (F)

Instituto de Efectividad Clínica y Sanitaria (IECS). Electronic address: fargento@iecs.org.

Manuel Donato (M)

Comisión Nacional de Evaluación de Tecnologías Sanitarias y Excelencia Clínica (CONETEC). Ministerio de Salud de la Nación Argentina.

Dario Villalba (D)

Hospital municipal "Santiago Fornos" de la ciudad de Chivilcoy.

Marisol García Sarubbio (MG)

Hospital Interzonal General de Agudos "General San Martín" de la ciudad de La Plata.

Anabella Giménez (A)

Hospital General de Agudos "Dr. Juan A. Fernández" de la Ciudad Autónoma de Buenos Aires.

Agustin Ciapponi (A)

Instituto de Efectividad Clínica y Sanitaria (IECS); CIESP, CONICET.

Federico Augustovski (F)

Instituto de Efectividad Clínica y Sanitaria (IECS); CIESP, CONICET.

Classifications MeSH